Research ArticleArticle
Metabolite Identification, Reaction Phenotyping, and Retrospective Drug-Drug Interaction Predictions of 17-Deacetylnorgestimate, the Active Component of the Oral Contraceptive Norgestimate
Deepak Ahire, Sarmistha Sinha, Barry Brock, Ramaswamy Iyer, Sandhya Mandlekar and Murali Subramanian
Drug Metabolism and Disposition June 2017, 45 (6) 676-685; DOI: https://doi.org/10.1124/dmd.116.073940
Deepak Ahire
Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Bangalore, India (D.A., S.S., M.S.); Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pennington, New Jersy (B.B., R.I.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb India Ltd., Bangalore, India: (S.M.)
Sarmistha Sinha
Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Bangalore, India (D.A., S.S., M.S.); Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pennington, New Jersy (B.B., R.I.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb India Ltd., Bangalore, India: (S.M.)
Barry Brock
Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Bangalore, India (D.A., S.S., M.S.); Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pennington, New Jersy (B.B., R.I.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb India Ltd., Bangalore, India: (S.M.)
Ramaswamy Iyer
Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Bangalore, India (D.A., S.S., M.S.); Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pennington, New Jersy (B.B., R.I.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb India Ltd., Bangalore, India: (S.M.)
Sandhya Mandlekar
Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Bangalore, India (D.A., S.S., M.S.); Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pennington, New Jersy (B.B., R.I.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb India Ltd., Bangalore, India: (S.M.)
Murali Subramanian
Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Bangalore, India (D.A., S.S., M.S.); Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pennington, New Jersy (B.B., R.I.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb India Ltd., Bangalore, India: (S.M.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Predicting 17-Deacetylnorgestimate Drug-Drug Interactions
Deepak Ahire, Sarmistha Sinha, Barry Brock, Ramaswamy Iyer, Sandhya Mandlekar and Murali Subramanian
Drug Metabolism and Disposition June 1, 2017, 45 (6) 676-685; DOI: https://doi.org/10.1124/dmd.116.073940
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement